ストックスクリーナーアプリを入手
1.78
1.36%
-0.06
Pacific Biosciences Of California Inc (PACB) 最新ニュース
PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up - Zacks Investment Research
PACB Q4 Deep Dive: Consumables and Clinical Adoption Drive Growth as SparkNex Launch Nears - TradingView
Pacific Biosciences's Q4 And Full-Year Revenue Improves - Nasdaq
Pacific Biosciences of California Inc (PACB) Q4 2025 Earnings Ca - GuruFocus
PacBio (PACB) Q4 2025 Earnings Call Transcript - The Globe and Mail
Pacific Biosciences of California Q4 2025 Earnings Call Transcript - MarketBeat
PacBio Announces Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail
Pacific Biosciences of California Q4 Earnings Call Highlights - MarketBeat
Pacific Biosciences of California (PACB) reports Q4 loss, beats revenue estimates - MSN
Earnings call transcript: Pacific Biosciences beats Q4 2025 forecasts By Investing.com - Investing.com Canada
PACB: Record consumable growth and SparkNex launch set stage for 8% revenue growth in 2026 - TradingView
PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025 - Finviz
Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Pacific Biosciences of California (NASDAQ:PACB) Announces Earnings Results - MarketBeat
Pacific Biosciences: Q4 Earnings Snapshot - kens5.com
PacBio (PACB) Surpasses Q4 Revenue Expectations Amid Strategic E - GuruFocus
PacBio (NASDAQ: PACB) lifts 2025 revenue but posts large restructuring-driven loss - Stock Titan
Pacific Biosciences of California joins iHope to expand genomic sequencing access - Traders Union
PacBio tech joins iHope to help rare disease patients get answers - Stock Titan
Valuation Update: Is Freedom Holding Corp in a bullish channelEarnings Performance Report & Real-Time Buy Signal Notifications - baoquankhu1.vn
Pacific Biosciences: Fourth Quarter Earnings Overview - Bitget
How strong is Pacific Biosciences of California Inc. stock revenue growth2025 Stock Rankings & Risk Controlled Stock Alerts - mfd.ru
PacBio Earnings: What To Look For From PACB - Finviz
Pacific Biosciences of California (NASDAQ:PACB) Is Carrying A Fair Bit Of Debt - 富途牛牛
How The Narrative Around Pacific Biosciences Of California (PACB) Is Shifting As Assumptions Evolve - Yahoo Finance
Buyback Watch: Will BIIB benefit from sector rotationPortfolio Value Summary & Daily Growth Stock Investment Tips - baoquankhu1.vn
Pacific Biosciences of California (PACB) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Risk Recap: Can Pacific Biosciences of California Inc. reach all time highs this yearWeekly Earnings Recap & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Pacific Biosciences showcases automation options at SLAS2026 - Traders Union
Pacific Biosciences Announces Interim Leadership Role Realignment - TipRanks
PacBio sells short-read DNA sequencing assets to Illumina for $48.1m - Investing.com Nigeria
Pacific Biosciences of California (NASDAQ:PACB) Shares Down 7.7%Here's Why - MarketBeat
Pacific Biosciences Sees Strategic Maneuvers Amid Financial Woes - StocksToTrade
Pacific Biosciences of California Closes $48.1 Million Sale of DNA Sequencing Assets to Illumina - marketscreener.com
PacBio (PACB) Finalizes Asset Sale to Illumina, Secures $48.1 Mi - GuruFocus
Pacific Biosciences Strengthens Balance Sheet via Asset Sale - TipRanks
Pacific Biosciences of California Signs Asset Purchase Agreement With Illumina Cambridge - TradingView
PacBio Completes Sale of Short-Read Sequencing Assets to Illumina for $48.1 Million - Quiver Quantitative
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Pacific Biosciences of California (NASDAQ:PACB) Stock Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market - sharewise.com
Pacific Biosciences of California (PACB) Stock Analysis: Navigating Growth Potential Amidst Market Challenges - DirectorsTalk Interviews
Pacific Biosciences of California unveils HiFiSequencing turning points at FOG2026 - Traders Union
Analyst Downgrade: Will Pacific Biosciences of California Inc outperform during market ralliesPrice Action & Safe Entry Point Alerts - baoquankhu1.vn
PacBio: The Consumables Flywheel Is Turning. The Chart Wants Confirmation (NASDAQ:PACB) - Seeking Alpha
PacBio To Report Q4 And FY25 Financial Results In Feb - Nasdaq
Pacific Biosciences showcases HiFi sequencing at FOG2026 in London - Traders Union
PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - Sahm
Pacific Biosciences stock shows signs of recovery, Canaccord maintains Buy By Investing.com - Investing.com Canada
How The New Price Target Is Reframing The Story For Pacific Biosciences (PACB) - Yahoo Finance
Pacific Biosciences of California (PACB) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Pacific Biosciences of California (NASDAQ:PACB) Hits New 52-Week HighTime to Buy? - MarketBeat
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable - simplywall.st
Pacific Biosciences of California (NASDAQ:PACB) Trading Up 7.9%Still a Buy? - MarketBeat
0.98%
0.65%
大文字化:
|
ボリューム (24 時間):